High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma

Abstract

Background: Primary adenosquamous carcinoma (ASC) is a rare malignant tumor in the lung and its biological behavior has not yet been thoroughly described. In this study, we aimed to explore the clinical and biological role of CXCR4 in patients with resected lung ASC. Methods: We retrospectively reviewed the clinical records of patients with histologically confirmed lung ASC who underwent surgical resection with systematic lymph node dissection. Immunohistochemical staining was performed to detect the expression of CXCR4 in tumor tissues. The correlation between CXCR4 expression and clinicopathological characteristics were evaluated. The association between CXCR4 expression and patients' prognosis was analyzed by Kaplan-Meier and Cox regression. Moreover, we performed in vitro studies including CCK8, transwell and cell apoptosis to explore the potential role of CXCR4 in lung ASC. Results:A total of 78 patients with resected lung ASC were reviewed. Seventy (89.7%) patient tumors expressed CXCR4, with high level of CXCR4 expression observed in 45 (57.7%) cases. In vitro, CXCR4 conferred no difference in proliferative capacity but increased invasive potential, enhanced chemoresistance and inhibited apoptosis of lung ASC. Clinically, high CXCR4 expression was significantly associated with solid ASC, lymph node metastasis and advanced TNM stage. Patients with high CXCR4 expression and solid ASC had decreased disease-free survival and overall survival. Conclusions: CXCR4 was commonly expressed in lung ASC tumors. High CXCR4 expression might be a novel marker in predicting a poor prognosis in resected lung ASC and might serve as a potential therapeutic target.

The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis

“…Fourteen out of 27 studies including 1899 patients with lung cancer evaluated the association between CXCR4 expression and overall survival (OS) [ 12 – 15 , 17 – 26 ]. The pooled HR showed that high CXCR4 expression was linked to decreased OS in lung cancer (HR 1.61, 95% CI 1.42–1.82, P < 0.001, I 2 = 32.2%) (Fig.…”

“…In addition, only 3 studies including 555 patients with resected lung cancer were enrolled to pool the HR for DFS [ 13 , 26 , 27 ]. All patients were treated with initial surgical resection.…”

Significance of hub genes and immune cell infiltration identified by bioinformatics analysis in pelvic organ prolapse

“…CXCR4 belongs to the G protein-coupled receptor superfamily and is expressed in a cortical protein-dependent manner on the cell surface ( Teicher & Fricker, 2010 ). CXCR4 has been reported to be overexpressed in a variety of tumor cells and is involved in tumor proliferation, invasion, metastasis, and worse prognosis ( Ottaiano et al, 2020 ; Wang et al, 2020a ; Zhu et al, 2020 ). GTP-binding protein overexpressed in skeletal muscle (GEM) is a GTPase originally identified in mitogen-stimulated T lymphocytes and v-Abl-transformed pre- B cells and is highly expressed in the spleen, thymus, and kidneys ( Cohen et al, 1994 ; Huang et al, 2014 ).…”

A549/DDP derived exosomes can affect cisplatin chemosensitivity via transporting CXCR4 to A549 cells

“…The high expression of CXCR4 promotes the aggressiveness of tumor cells, enhances chemoresistance and inhibits cell apoptosis. Clinically, high CXCR4 expression may be related to the poor prognosis of lung cancer patients (Zhu et al, 2020). It has been reported that the CXCR4-inhibiting nanocomplex reduces tumor fibrosis and promotes cytotoxic T lymphocytes penetration, regulating the lung immune response, thereby further enhancing the anti-PD-L1 immune response (Li et al, 2020b).…”